InvestorsHub Logo
Followers 44
Posts 864
Boards Moderated 0
Alias Born 03/08/2014

Re: kabunushi post# 257142

Friday, 12/27/2019 7:21:40 AM

Friday, December 27, 2019 7:21:40 AM

Post# of 700689
My point was not that some or even perhaps a majority of BP execs may be asleep at the switch but that not all of them would be especially wrt a paradigm changing treatment for GBM and indeed many solid tumours. Rather, I think it more likely that it is a valuation issue where NWBO and BP may be far apart. This may change if TLD is very positive. I don't believe that BP is blind to the potential of DC VAX as a mono-therapy or combination cocktail. Surely Dr. Duffy has recognised this and it is rather certain that BP realises it as well. Bottom line, I think it is a valuation issue which may be better bridged by TLD and follow-on deep dive analysis. JMHO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News